News
Here are four promising growth stocks that can help increase the value of your investment portfolio. The post Looking for ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its ...
Simulations using mathematical models further supported why AC_Var — a CGM-derived index — could detect declines in glycemic control earlier than traditional indicators such as fasting glucose. In ...
Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...
Singer-actor Nick Jonas recently took to social media to talk about his battle with diabetes. He revealed how being diagnosed with it at the age of 13 changed his life. Wife Priyanka Chopra took to ...
Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...
Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...
The Diabetes Link organization organized a diabetes tech seminar that brought together individuals with Type 1 diabetes, ...
DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results